Cure51 is a Paris-based company that has created the first global database of exceptional cancer survivors, with a focus on paving the way for new therapies. They have recently raised a €15M Seed round to further their mission. Cure51 aims to lead the path to new therapies against cancer by utilizing clinical and molecular data from survivors.

CURE 51, Paris. 18 likes. First global database of exceptional cancer survivors, paving the way for new therapies.

Cure51 raises a €15M Seed round aiming to crack the code on cancer survival https://t.co/XzSejmnzkt.

The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer. Website: http://www.cure51.

Cure51

Find contacts at this company